NDT Pharmaceuticals, Inc. (NDTP)
OTHER OTC:NDTP
US Market
Holding NDTP?
Track your performance easily

NDT Pharmaceuticals (NDTP) Financial Statements

8 Followers

NDT Pharmaceuticals Financial Overview

NDT Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $0; its P/E ratio is -650.00; NDT Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 08Dec 07Sep 07Jun 07Mar 07
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -20.75K$ -21.34K$ -18.14K$ -11.80K$ -10.15K
EBITDA$ -20.75K$ -21.34K$ -18.14K$ -11.80K$ -10.15K
Net Income Common Stockholders$ -20.82K$ -998.77K$ -18.14K$ -11.80K$ -10.15K
Balance Sheet-
Cash Cash Equivalents And Short Term Investments$ 8.16K$ 7.68K$ 499.53K$ 4.40K$ 18.10K
Total Assets$ 187.70K$ 108.92K$ 1.00M$ 4.40K$ 18.78K
Total Debt$ 154.53K$ 101.23K$ 0.00$ 0.00$ 0.00
Net Debt$ 146.37K$ 93.55K$ -499.53K$ -4.40K$ -18.10K
Total Liabilities$ 172.25K$ 124.65K$ 20.66K$ 9.38K$ 13.97K
Stockholders Equity$ 15.44K$ -15.73K$ 981.04K$ -4.99K$ 4.81K
Cash Flow-
Free Cash Flow$ -49.52K$ -16.85K$ -7.37K$ -13.70K$ -1.53K
Operating Cash Flow$ -49.52K$ -16.85K$ -7.37K$ -13.70K$ -1.53K
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 50.00K$ -475.00K$ 502.50K$ 0.00$ -58.00K
Currency in USD

NDT Pharmaceuticals Earnings and Revenue History

NDT Pharmaceuticals Debt to Assets

NDT Pharmaceuticals Cash Flow

NDT Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis